Project Number 5R01AG069900-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development a. Enabling Technologies Researcher and Organization Principal Investigator WEN, ZHEXING Principal Investigator First Name ZHEXING Principal Investigator Last Name WEN Awardee Organization VANDERBILT UNIVERSITY Awardee State Tennessee Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-17-032: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01) FY Overall Cost $799,966 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official ARUNKUMAR, NANDINI
